Hiroshi Kasamatsu

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Acute generalized exanthematous pustulosis induced by eperisone hydrochloride in a psoriasis patient on anti-IL-23p19 antibody therapy: evidence of an IL-23 axis-independent milieu.

Acute generalized exanthematous pustulosis induced by eperisone hydrochloride in a psoriasis patient on anti-IL-23p19 antibody therapy: evidence of an IL-23 axis-independent milieu.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Cutaneous Indeterminate Cell Histiocytosis in a Young Child: A Case Report and Literature Review.

Cutaneous Indeterminate Cell Histiocytosis in a Young Child: A Case Report and Literature Review.

Journal: The Journal of dermatology

Published: January 19, 2026

Author Correction: GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Author Correction: GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Journal: Nature communications

Published: January 19, 2026

A Serum N-Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis.

A Serum N-Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis.

Journal: The Journal of dermatology

Published: January 04, 2026

Difamilast Ointment, a Topical PDE4 Inhibitor, for Pediatric Cheilitis Granulomatosa: A Steroid-Sparing Outcome.

Difamilast Ointment, a Topical PDE4 Inhibitor, for Pediatric Cheilitis Granulomatosa: A Steroid-Sparing Outcome.

Journal: The Journal of dermatology

Published: October 27, 2025

Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.

Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.

Journal: Arthritis research & therapy

Published: July 14, 2023

A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.

A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.

Journal: The Journal of dermatology

Published: July 06, 2023

A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.

A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.

Journal: Arthritis research & therapy

Published: May 01, 2023

GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Journal: Nature communications

Published: March 20, 2023

Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.

Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.

Journal: The Journal of dermatology

Published: July 03, 2022

Retrospective evaluation of the utility of two-step surgery for facial basal cell carcinoma and squamous cell carcinoma.

Retrospective evaluation of the utility of two-step surgery for facial basal cell carcinoma and squamous cell carcinoma.

Journal: Frontiers in surgery

Published: April 08, 2022

The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.

The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.

Journal: Arthritis research & therapy

Published: May 17, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026